Ipatasertib is an oral kinase inhibitor and investigational therapeutic agent that functions by targeting all three isoforms of AKT, making it a critical focus in the study of PI3K/AKT pathway modulation… Read more
![Chemical structure of (2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1001264-89-6-2S-2-4-Chlorophenyl-1-4-5R7R-67-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl-1-piperazinyl-3-1-methylethylamino-1-propanone.png&w=3840&q=75)
![Chemical structure of (5R,7R)-5-Methyl-4-(piperazin-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-7-ol Dihydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1001269-85-7-5R7R-5-Methyl-4-piperazin-1-yl-67-dihydro-5H-cyclopentadpyrimidin-7-ol-Dihydrochloride.png&w=3840&q=75)
Ipatasertib is an oral kinase inhibitor and investigational therapeutic agent that functions by targeting all three isoforms of AKT, making it a critical focus in the study of PI3K/AKT pathway modulation for the treatment of solid tumors and multiple myeloma. This category features high-quality reference standards essential for comprehensive pharmaceutical analysis, including Ipatasertib API, related synthetic impurities, and stable isotope labelled compounds. These materials are indispensable for researchers and quality control laboratories engaged in impurity profiling and the validation of analytical methods. By providing precise, characterized reference materials, these compounds support the rigorous quantification of degradation products and metabolic intermediates during the development and regulatory submission processes. Whether utilizing stable isotope labelled standards as internal standards for mass spectrometry or assessing specific impurities to ensure product safety, these resources facilitate accurate, compliant pharmaceutical testing throughout the drug development lifecycle.